HLA-DR-promiscuous T cell epitopes frown Plasmodium falciparum pre- erythrocytic-stage antigens restricted by multiple HLA class II alleles

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 1123-1137

  Doolan, Denise L ^a   Southwood, Scott ^b   Chesnut, Robert ^b   Appella, Ettore ^b   Gomez, Eduardo ^c   Richards, Allen ^c   Higashimoto, Yuichiro I ^b   Maewal, Ajesh ^b   Sidney, John ^b   Gramzinski, Robert A ^c   Mason, Carl ^d   Koech, Davy ^d   Hoffman, Stephen L ^a   Sette, Alessandro ^b  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Epimmune   (United States)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ALLELE; ANTIGENICITY; ARTICLE; CYTOKINE PRODUCTION; ERYTHROCYTE; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE;

EID: 0034661982     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.1123     Document Type: Article

References (60)

1. World Health Organization. 1996. Malaria Fact Sheet No. 94. World Health Organization, Geneva, Switzerland.
2. Hoffman, S. L., E. D. Franke, M. R. Hollingdale, and P. Druilhe. 1996. Attacking the infected hepatocyte. In Malaria Vaccine Development, Ch. 3. S. L. Hoffman, ed. ASM Press, Washington, D.C., p. 35.
3. Doolan, D. L., B. Wizel, and S. L. Hoffman. 1996. Class I restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs. Immunol. Res. 15:280.
4. + T cell- and IFN-γ dependent elimination of infected hepatocytes. J. Immunol. 157:4061.
5. + T-cell- and γ interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect. Immun. 67:5604.
6. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M. F. Leef, M. Sedegah, L. F. Yuan, F. A. Robey, R. L. Beaudoin, and S. L. Hoffman. 1991. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelli sporozoites. J. Immunol. 146:1020.
7. del Guercio, M. F., J. Alexander, R. T. Kubo, T. Arrhenius, A. Maewal, E. Appella, S. L. Hoffman, T. Jones, D. Valmori, K. Sakaguchi, H. M. Grey, and A. Sette. 1997. Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. Vaccine 15:441.
8. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201.
9. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supertypes. Immunol. Today 17:261.
10. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wentworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, et al. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97.
11. Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503.
12. Chang, K. M., N. H. Gruener, S. Southwood, J. Sidney, G. R. Pape, F. V. Chisari, and A. Sette. 1999. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J. Immunol. 162:1156.
13. + T cells in hepatitis C virus-exposed healthy seronegative donors. J. Immunol. 162:6681.
14. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
15. Southwood, S., J. Sidney, A. Kondo, M. F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363.
16. Gulukota, K., J. Sidney, A. Sette, and C. DeLisi. 1997. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J. Mol. Biol. 267:1258.
17. Campbell, J. R. 1989. DNA sequence of the gene encoding a Plasmodium falciparum malaria candidate vaccine antigen. Nucleic Acids Res. 17:5854.
18. Rogers, W. O., A. Malik, S. Mellouk, K. Nakamura, M. D. Rogers, A. Szarfman, D. M. Gordon, A. K. Nussler, M. Aikawa, and S. L. Hoffman. 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. USA 89:9176.
19. Zhu, J., and M. R. Hollingdale. 1991. Structure of Plasmodium falciparum liver stage antigen-1. Mol. Biochem. Parasitol. 48:223.
20. Sanchez, G. I., W. O. Rogers, S. Mellouk, and S. L. Hoffman. 1994. Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver-stage parasites. Exp. Parasitol. 79:59.
21. O'Sullivan, D., T. Arrhenius, J. Sidney, M. F. Del Guercio, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colon, F. C. Gaeta, and A. Sette. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles: identification of common structural motifs. J. Immunol. 147:2663.
22. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
23. Sidney, J., S. Southwood, C. Oseroff, M. F. del Guercio, A. Sette, and H. M. Grey. 1998. The measurement of MHC/peptide interactions by gel infiltration. Curr. Protocols Immunol. 18:3.1.
24. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1994. Pool sequencing of natural HLA-DR, DQ, DP ligands reveals detailed peptide motifs, constraints of processing and general rules. Immunogenetics 39:230.
25. Wu, S., K. Maslanka, and J. Gorski. 1997. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J. Immunol. 158:3221.
26. Ponnudurai, T., A. D. E. M. Leeuwenberg, and J. H. Meuwissen. 1981. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop. Geog. Med. 33:50.
27. Walliker, D., I. A. Quakyi, T. E. Wellems, T. F. McCutchan, A. Szarfman, W. T. London, L. M. Corcoran, T. R. Burkot, and R. Carter. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236:1661.
28. Egan, J. E., S. L. Hoffman, J. D. Haynes, J. C. Sadoff, I. Schneider, G. E. Grau, M. R. Hollingdale, W. R. Ballou, and D. M. Gordon. 1993. Humoral immune response in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49:166.
29. Malik, A., J. E. Egan, R. A. Houghton, J. C. Sadoff, and S. L. Hoffman. 1991. Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 88:3300.
30. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766.
31. Wizel, B., R. A. Houghten, K. Parker, J. E. Coligan, P. Church, D. M. Gordon, W. R. Ballou, and S. L. Hoffman. 1995. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum surface sporozoite protein 2. J. Exp. Med. 182:1435.
32. Beier, J. C., C. N. Oster, F. K. Onyango, J. D. Bales, J. A. Sherwood, P. V. Perkins, D. K. Chumo, D. V. Koech, R. E. Whitmire, C. R. Roberts, C. L. Diggs, and S. L. Hoffman. 1994. Plasmodium fulciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am. J. Trop. Med. Hyg. 50:529.
33. McElroy, P. D., J. C. Beier, C. N. Oster, C. Beadle, J. A. Sherwood, A. J. Oloo, and S. L. Hoffman. 1994. Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am. J. Trop. Med. Hyg. 51:523.
34. Beadle, C., P. D. McElroy, C. N. Oster, J. C. Beier, A. J. Oloo, F. K. Onyango, D. K. Chumo, J. D. Bales, J. A. Sherwood, and S. L. Hoffman, 1995. Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine design. J. Infect. Dis. 172:1047.
35. Hoffman, S. L., C. N. Oster, C. Mason, J. C. Beier, J. A. Sherwood, W. R. Ballou, M. Mugambi, and J. D. Chulay. 1989. Human lymphoctye proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J. Immunol. 142:1299.
36. Hoffman, S. L., C. N. Oster, C. V. Plowe, G. R. Woollett, J. C. Beier, J. D. Chulay, R. A. Wirtz, M. R. Hollingdale, and M. Mugambi. 1987. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 237:639.
37. Baird, J. K., T. R. Jones, E. W. Danudirgo, B. A. Annis, M. J. Bangs, H. Basri, Purnomo, and S. Masbar. 1991. Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am. J. Trop. Med. Hyg. 45:65.
38. Jones, T. R., J. K. Baird, M. J. Bangs, B. A. Annis, Purnomo, H. Basri, S. Gunawan, S. Harjosuwarno, P. D. McElroy, and S. L. Hoffman. 1994. Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements and epidemiologic considerations in sample size estimation. Am. J. Trop. Med. Hyg. 50:210.
39. Ohrt, C., T. L. Richie, H. Widjaja, G. D. Shanks, J. Fitriadi, D. J. Fryauff, J. Handschin, D. Tang, B. Sandjaja, E. Tjitra, et al. 1997. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126: 963.
40. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobori. 1992. Allele and Haplotype Frequencies for HLA and Complement Loci in Various Ethnic Groups. Oxford University Press, Tokyo.
41. Tiwari, J. L., and P. I. Terasaki. 1985. The HLA complex. In HLA and Disease Associations. New York, Springer-Verlag.
42. Osborne, M. J., and A. Rubinstein. 1994. A Course in Game Theory. MIT Press, Cambridge, MA.
43. Good, M. F., D. Pombo, I. A. Quakyi, E. M. Riley, R. A. Houghten, A. Menon, D. W. Alling, J. A. Berzofsky, and L. H. Miller. 1987. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 85:1199.
44. Zevering, Y., R. A. Houghten, I. H. Frazer, and M. F. Good. 1990. Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int. Immunol. 2:945.
45. Fidock, D. A., H. Gras Masse, J. P. Lepers, K. Brahimi, L. Benmohamed, S. Mellouk, C. Guerin Marchand, A. Londono, L. Raharimalala, J. F. Meis, et al. 1994. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153:190.
46. Vogel, S. N., and R. M. Friedman. 1991. Measurement of antiviral activity induced by inerferons α, β, and γ. In Current Protocols in Immunology, Ch. 6.9.1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Straober, eds. Wiley Interscience, National Institutes of Health, Bethesda, MD.
47. + T cell epitope of Plasmodium falciparum. Immunity 10:651.
48. Kurtis, J. D., D. E. Lanar, M. Opollo, and P. E. Duffy. 1999. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect. Immun. 67:3424.
49. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class 1 binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153.
50. Sinigaglia, F., M. Guttinger, J. Kilgus, D. M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J. R. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336:778.
51. + T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol. 3:997.5586.
52. + T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes: implications for HLA class I and II allelic linkage to disease susceptibility. Hum. Immunol. 60:652.
53. ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int. J. Cancer 72:784.
54. Lehtinen, M., M. H. Hibma, G. Stellato, T. Kuoppala, and J. Paavonen. 1995. Human T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papillomavirus type 16. Biochem. Biophys. Res. Commun. 209:541.
55. + T cell epitopes map to the same region of the malaria circumsporozoite protein: limited immunogenicity of sporozoites and circumsporozoite protein. Mol. Biol. Med. 5:185.
56. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. M. Feinstone, and J. A. Berzofsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334.
57. Nehete, P. N., S. J. Schapiro, P. C. Johnson, K. K. Murthy, W. C. Satterfield, and K. J. Sastry. 1998. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans. Viral Immunol. 11:147.
58. Connelly, M., C. L. King, K. Bucci, S. Walters, B. Genton, M. P. Alpers, M. Hollingdale, and J. W. Kazura. 1997. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65:5082.
59. Flanagan, K. L., M. Plebanski, P. Akinwunmi, E. A. Lee, W. H. Reece, K. J. Robson, A. V. Hill, and M. Pinder. 1999. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans. Eur. J. Immunol 29:1943.
60. Doolan, D. L., and S. L. Hoffman. 1997. Multi-gene vaccination against malaria: a multi-stage, multi-immune response approach. Parasitol. Today 13:171.